Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents

Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to be converted to morphine faster and more completely than in other people. These people with genetic differences (ultra-rapid metabolizers) are more likely to have higher than normal amounts of morphine in their blood after taking codeine. High levels of morphine can result in breathing difficulty, which may cause death. 2024-05-08 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetySummary Safety ReviewCODEINEassessingbreathing problemschildren and adolescentsliverliver enzymesgenetic differencesultra-rapid metabolizers Summary Safety Review - CODEINE PRESCRIPTION PRODUCTS Indicated for Cough - Further Assessing the Risk of Serious Breathing Problems in Children and AdolescentsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-produits-ordonnance-contenant-codeine-indiques-toux-evaluation-approfondie-risque-problemes-respiratoires-graves-chez-enfants.html

Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to be converted to morphine faster and more completely than in other people. These people with genetic differences (ultra-rapid metabolizers) are more likely to have higher than normal amounts of morphine in their blood after taking codeine. High levels of morphine can result in breathing difficulty, which may cause death.

Data and Resources

Similar records